Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Phase 1b Safety and Efficacy Study of TRU-016
- Status
- TERMINATED
- Phase
- PHASE1
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Stem Cell Transplant for CLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
- Status
- COMPLETED
- Phase
- PHASE2
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
- Status
- COMPLETED
- Phase
- PHASE3
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)
- Status
- TERMINATED
- Phase
- PHASE3
IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1